RxDoctor Payments Data

Betty Jordan, MD

Family Medicine · Tarboro, NCNPI 1811197320

Payments from drug & device makers

$1,450in general payments, 2019–2025

Across 76 payments — averaging $19.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$675
  • Novo Nordisk$156
  • Lilly USA, LLC$143
  • GSK$52
  • Amgen$52
  • Abiomed$47
  • plus $326 from 12 others

What the payments were for

  • Food & beverage$1,450100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,450 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$65,421
Medicare patients
158
Services billed
1,341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin86$104,100
EliquisApixaban81$77,943
OzempicSemaglutide45$54,384
MounjaroTirzepatide11$27,659
SynjardyEmpagliflozin/Metformin Hcl16$22,124
TrulicityDulaglutide17$20,313
FarxigaDapagliflozin Propanediol17$14,143
LinzessLinaclotide12$13,097
EntrestoSacubitril/Valsartan12$12,036
MyrbetriqMirabegron15$11,730
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog16$10,276
Tresiba Flextouch U-100Insulin Degludec28$9,752
Breo ElliptaFluticasone/Vilanterol15$9,575
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,917
Janumet XrSitagliptin Phos/Metformin Hcl13$6,295

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy, Stiolto Respimat$28$132,237113 claims
PfizerEliquis, Paxlovid$42$79,302103 claims
Novo NordiskOzempic$156$54,38445 claims
Lilly USA, LLCMounjaro, Trulicity$143$47,97228 claims
AstraZenecaFarxiga, Symbicort$29$19,50729 claims
GSKBreo Ellipta, Trelegy Ellipta$52$16,49326 claims
AbbVieLinzess, Synthroid$18$15,85156 claims
MerckJanumet Xr$13$6,29513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Tarboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →